Amundi
ERAS icon

Amundi’s Erasca ERAS Stock Holding History

Amundi’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-80
Closed -$97 – 1824
2025
Q1 		$97 Sell
80
-287
-78% -$493 ﹤0.01% 2171
2024
Q4 		$1.01K Buy
+367
New +$1.01K ﹤0.01% 2024

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Amundi's ERAS Position: Q2 2025 in Review

Amundi sold out of Erasca (ERAS) in Q2 2025, closing a stake of 80 shares — an estimated $97 sold.

Amundi first reported a position in ERAS in Q4 2024 and held it in 2 quarters. The position peaked at $1.01K in Q4 2024. 142 funds tracked by Wall St. Rank hold ERAS as of Q2 2025.

  • Amundi reported no remaining Erasca position as of Q2 2025 after selling out during the quarter.
  • Amundi sold 80 Erasca shares in Q2 2025, an estimated $97.
  • Amundi first reported a position in Erasca in Q4 2024 and held it in 2 quarters.
  • Amundi's Erasca position peaked at $1.01K in Q4 2024.
  • 142 funds tracked by Wall St. Rank held Erasca as of Q2 2025.

Based on Amundi's 13F filing for Q2 2025, filed 13 Aug 2025.